195 related articles for article (PubMed ID: 36182976)
1. Thyroid-Stimulating Hormone, Age, and Tumor Size are Risk Factors for Progression During Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma in Adults.
Ito Y; Miyauchi A; Fujishima M; Noda T; Sano T; Sasaki T; Kishi T; Nakamura T
World J Surg; 2023 Feb; 47(2):392-401. PubMed ID: 36182976
[TBL] [Abstract][Full Text] [Related]
2. Effect of TSH levels during active surveillance of PTMC according to age.
Kim HI; Jin M; Ko NG; Oh YL; Shin JH; Kim JH; Kim JS; Jeon MJ; Kim TY; Kim SW; Kim WB; Chung JH; Shong YK; Kim WG; Kim TH
Endocr Relat Cancer; 2022 Mar; 29(4):191-200. PubMed ID: 35099407
[TBL] [Abstract][Full Text] [Related]
3. Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.
Lee EK; Moon JH; Hwangbo Y; Ryu CH; Cho SW; Choi JY; Chung EJ; Jeong WJ; Jung YS; Ryu J; Kim SJ; Kim MJ; Kim YK; Lee CY; Lee JY; Yu HW; Hah JH; Lee KE; Lee YJ; Park SK; Park DJ; Kim JH; Park YJ
Thyroid; 2022 Nov; 32(11):1328-1336. PubMed ID: 36205563
[No Abstract] [Full Text] [Related]
4. High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance.
Kim HI; Jang HW; Ahn HS; Ahn S; Park SY; Oh YL; Hahn SY; Shin JH; Kim JH; Kim JS; Chung JH; Kim TH; Kim SW
J Clin Endocrinol Metab; 2018 Feb; 103(2):446-451. PubMed ID: 29211863
[TBL] [Abstract][Full Text] [Related]
5. Association between preoperative serum TSH and tumor status in patients with papillary thyroid microcarcinoma.
Mao A; An N; Wang J; Wu Y; Wang T; Wang Z; Guan H; Wang J
Endocrine; 2021 Sep; 73(3):617-624. PubMed ID: 33755880
[TBL] [Abstract][Full Text] [Related]
6. Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status.
Yamamoto M; Miyauchi A; Ito Y; Fujishima M; Sasaki T; Kudo T
Thyroid; 2023 Oct; 33(10):1182-1189. PubMed ID: 37310904
[No Abstract] [Full Text] [Related]
7. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
[No Abstract] [Full Text] [Related]
8. Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience.
Miyauchi A; Ito Y; Fujishima M; Miya A; Onoda N; Kihara M; Higashiyama T; Masuoka H; Kawano S; Sasaki T; Nishikawa M; Fukata S; Akamizu T; Ito M; Nishihara E; Hisakado M; Kosaka K; Hirokawa M; Hayashi T
Thyroid; 2023 Jul; 33(7):817-825. PubMed ID: 37166389
[No Abstract] [Full Text] [Related]
9. Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.
Gao Y; Qu N; Zhang L; Chen JY; Ji QH
Tumour Biol; 2016 Jun; 37(6):7453-9. PubMed ID: 26678888
[TBL] [Abstract][Full Text] [Related]
10. US Predictors of Papillary Thyroid Microcarcinoma Progression at Active Surveillance.
Lee JY; Kim JH; Kim YK; Lee CY; Lee EK; Moon JH; Choi HS; Yul H; Cho SW; Kim SJ; Lee KE; Park DJ; Park YJ
Radiology; 2023 Oct; 309(1):e230006. PubMed ID: 37906009
[TBL] [Abstract][Full Text] [Related]
11. Active surveillance for adult low-risk papillary thyroid microcarcinoma-a review focused on the 30-year experience of Kuma Hospital.
Ito Y; Miyauchi A; Fujishima M; Yamamoto M; Sasaki T
Endocr J; 2024 Jan; 71(1):7-21. PubMed ID: 37793883
[TBL] [Abstract][Full Text] [Related]
12. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.
Ito Y; Miyauchi A; Kihara M; Higashiyama T; Kobayashi K; Miya A
Thyroid; 2014 Jan; 24(1):27-34. PubMed ID: 24001104
[TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid microcarcinoma might progress during pregnancy.
Shindo H; Amino N; Ito Y; Kihara M; Kobayashi K; Miya A; Hirokawa M; Miyauchi A
Thyroid; 2014 May; 24(5):840-4. PubMed ID: 24397849
[TBL] [Abstract][Full Text] [Related]
14. Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital.
Ito Y; Miyauchi A; Kudo T; Ota H; Yoshioka K; Oda H; Sasai H; Nakayama A; Yabuta T; Masuoka H; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
Thyroid; 2016 Jan; 26(1):156-60. PubMed ID: 26670937
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
Kim WY; Kim HY; Son GS; Bae JW; Lee JB
J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
[TBL] [Abstract][Full Text] [Related]
16. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
17. Insights into the Management of Papillary Microcarcinoma of the Thyroid.
Miyauchi A; Ito Y; Oda H
Thyroid; 2018 Jan; 28(1):23-31. PubMed ID: 28629253
[TBL] [Abstract][Full Text] [Related]
18. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
[No Abstract] [Full Text] [Related]
19. Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases.
Medas F; Canu GL; Cappellacci F; Boi F; Lai ML; Erdas E; Calò PG
Front Endocrinol (Lausanne); 2020; 11():551. PubMed ID: 32982963
[No Abstract] [Full Text] [Related]
20. [Relationship between serum thyroxin-stimulating hormone and papillary thyroid micrcarcinoma in nodular thyroid disease].
Jiao J; Zhou Y
Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(12):908-11. PubMed ID: 26081052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
